Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 3
  • 5
  • 3
  • 5

Found 5 Ulcers trials

A listing of Ulcers medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Adaptive phase III trial to investigate the efficacy and safety of vilobelimab in the treatment of ulcerative pyoderma gangrenosum

Adaptive phase III trial to investigate the efficacy and safety of vilobelimab in the treatment of ulcerative pyoderma gangrenosum

All genders
This study aims to find out if a new investigational drug, vilobelimab (also called IFX-1) is safe and effective in treating subjects 18 and older diagnosed Ulcerative Pyoderma Gangrenosum. Procedures include blood and urine tests, a physical examination, vital signs, body weight and height, an electrocardiogram (ECG), and full assessment …

A Multicenter Randomized Double-Blind Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy

All genders
Phase 3
The trial will enroll subjects who have had an inadequate response (IR) to prior biologic therapy (bio-IR). The bio-IR population is defined as subjects with documented intolerance or inadequate response to one or more of the approved biologics for UC (infliximab, adalimumab, golimumab, and/or vedolizumab).

Boomerang Early Feasibility Study

18-75 years
All genders
Interventional
The purpose of this research study is to learn more about the safety and performance of Sacral Nerve Stimulation when used in patients who have Crohn’s disease or ulcerative colitis. The InterStim™ Neurostimulator (InterStim) will be used in every participant who agrees to participate and meets all the eligibility criteria …

ARISE Pivotal

All genders
Assess the safety and effectiveness of the ASG (Ascending Stent Graft) device in the treatment of lesions involving the ascending aorta and aortic arch. This study involves patients considered to be at high-risk for open surgical repair who present with the following pathologies of the ascending aorta and aortic arch …
 DECODE Biologic-Describing the Consequences of Delays in Biologic initiation Study

DECODE Biologic-Describing the Consequences of Delays in Biologic initiation Study

18-99 years
All genders
This study plans to learn more about the usage and effect of biologic medications with patients that have inflammatory bowel disease (IBD). IBD includes both Crohn’s Disease (CD) and Ulcerative Colitis (UC), which currently affects around 1.5 million Americans. Medical therapies for IBD focus on reducing the inflammation of the …